Series date: 
01/01/2023 - 12:00am EST to 12/31/2023 - 11:59pm EST

Description

This multidisciplinary tumor board series reviews patients with newly diagnosed solid tumors as well as patients with refractory or relapsed disease. Included are representatives from oncology (multiple centers in the region), surgery, radiation oncology, pathology, and radiology. The primary objective is to review each case, present the relevant literature and develop a comprehensive evidence-based treatment plan.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Medical Society of Virginia (MSV) through the joint providership of Inova Health System Office of Continuing Medical Education and Children’s National Hospital. The Inova Health System Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.

Disclosure Policy 

Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME. All relevant conflicts of interest have been mitigated prior to the commencement of this activity.

Series location: 
Virtual
United States